Liren Li Selected Research

Adjuvant Chemotherapy

1/2021	Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer.
1/2019	High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.
7/2011	Optimal use of adjuvant chemotherapy in stage II colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liren Li Research Topics

Disease

20	Neoplasms (Cancer) 08/2022 - 01/2012
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2002
6	Pain (Aches) 11/2021 - 11/2016
6	Colitis 01/2016 - 01/2013
5	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2002
4	Neuralgia (Stump Neuralgia) 01/2022 - 01/2020
4	Inflammation (Inflammations) 01/2022 - 06/2015
4	Rectal Neoplasms (Rectal Cancer) 12/2018 - 08/2016
3	Fatigue 08/2022 - 01/2020
3	Melanoma (Melanoma, Malignant) 02/2019 - 09/2014
3	Ulcerative Colitis 01/2016 - 06/2015
2	Infections 09/2021 - 01/2021
2	Gout 10/2018 - 07/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 04/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 03/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2022
1	Sleepiness 02/2022
1	Peripheral Nerve Injuries 01/2022
1	Dengue (Dengue Fever) 09/2021
1	Flavivirus Infections 09/2021
1	Virus Diseases (Viral Diseases) 09/2021
1	Hyperalgesia 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Hypertension (High Blood Pressure) 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2017
1	Adenocarcinoma 10/2017
1	Adenocarcinoma of Lung 01/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
5	Biological ProductsIBA 01/2016 - 03/2012
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2022 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2012
3	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2017
3	Pharmaceutical PreparationsIBA 09/2021 - 07/2018
3	Messenger RNA (mRNA)IBA 09/2021 - 01/2017
3	Capecitabine (Xeloda)FDA Link 01/2019 - 07/2011
3	Caspase 3 (Caspase-3)IBA 01/2016 - 02/2015
2	CytokinesIBA 01/2022 - 10/2015
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2012
2	Antiviral Agents (Antivirals)IBA 09/2021 - 01/2021
2	Circulating Tumor DNAIBA 01/2021 - 01/2019
2	Nuclear Receptor Coactivator 3IBA 11/2020 - 01/2018
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2020 - 03/2012
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2014
2	VemurafenibIBA 02/2019 - 09/2014
2	MelatoninIBA 02/2019 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 10/2017
2	Carcinoembryonic AntigenIBA 01/2019 - 03/2013
2	Uric Acid (Urate)IBA 10/2018 - 07/2017
2	Cytochromes c (Cytochrome c)IBA 01/2018 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2017
2	Antirheumatic Agents (DMARD)IBA 11/2016 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 06/2015
2	Carrier Proteins (Binding Protein)IBA 10/2015 - 01/2014
2	SodiumIBA 01/2014 - 05/2012
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Sirtuin 1IBA 09/2021
1	Sirtuin 2IBA 09/2021
1	Dengue VaccinesIBA 09/2021
1	Viral ProteinsIBA 09/2021
1	Anti-Infective Agents (Microbicides)IBA 09/2021
1	SirtuinsIBA 09/2021
1	tenovin-1IBA 09/2021
1	brivanibIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Calcibiotic Root Canal SealerIBA 01/2021
1	AntagomirsIBA 01/2021
1	LipidsIBA 01/2021
1	Protein Tyrosine PhosphatasesIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 01/2020
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2019
1	Epithelial Cell Adhesion MoleculeIBA 02/2019
1	LuciferasesIBA 02/2019
1	Proto-Oncogene Proteins B-rafIBA 02/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	AntigensIBA 01/2019
1	CarbohydratesIBA 01/2019
1	Differentiation AntigensIBA 01/2018
1	CaspasesIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	NVP-BKM120IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 11/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2017
1	Colchicine FDA LinkGeneric 11/2017
1	XELOXIBA 10/2017
1	C-Reactive ProteinIBA 05/2017
1	ametantrone (HAQ)IBA 05/2017

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2014
4	Chemoradiotherapy 12/2018 - 08/2016
3	Ligation 11/2021 - 01/2020
3	Adjuvant Chemotherapy 01/2021 - 07/2011
1	Oral Administration 01/2021
1	Colectomy 11/2019
1	Drug Therapy (Chemotherapy) 12/2018
1	Radiotherapy 10/2017